FMCQF Fresenius Medical Care AG

Overview and Growth

In fiscal 2013, Fresenius Medical Care AG recorded $4.97B of revenue, net income of $1.11B, and an operating cash inflow of $2.03B. The $4.97B revenue base provides substantial context for the company’s earnings, cash generation, and capital requirements. On a per-share basis, diluted EPS was $3.65, which connects the reported earnings outcome with the company’s diluted share count. Against diluted EPS of $3.87 in fiscal 2012, the current result was 5.7% lower. The company employed $23.12B of total assets, the balance-sheet base supporting its current operating and cash-flow results. Revenue equaled 0.21x of total assets, indicating how much reported top-line activity the company produced relative to its period-end asset base.

Profitability

Gross profit was $4.74B, representing the portion of revenue remaining after the reported cost of revenue and before operating expenses. Gross profit represented 95.3% of revenue, showing how much of the top line remained after direct costs. Operating income was $2.26B, the earnings remaining from reported operations after the company’s recognized operating cost structure. The operating result equaled 45.4% of revenue, placing the absolute operating-income figure in the context of the company’s sales base. The bottom-line result was net income of $1.11B, after the operating, financing, tax, and other items recognized for the period. Net margin was 22.3%, meaning that this portion of revenue remained as net income after all recognized expenses. Income tax expense totaled $592.01M, providing the reported tax component that separates pretax and after-tax earnings. Return on period-end equity was 11.7%, relating annual net income to the equity capital on the balance sheet. Return on period-end assets was 4.8%, connecting net income with the company’s total asset base.

Liquidity and Capital Structure

The near-term balance sheet paired $6.29B of current assets with $3.55B of current liabilities at the reporting date. At 1.77x, the current ratio shows that short-term assets were greater than short-term liabilities at period end. Cash and equivalents totaled $682.78M, identifying the most liquid reported component available within the broader current-asset balance. Measured only with cash and equivalents, coverage of current liabilities was 19.2%, excluding receivables and other current assets. The company carried $7.84B of total debt at period end, which frames its leverage and debt-service burden. Against book equity, debt measured 0.83x, placing the company’s financial leverage in clear balance-sheet terms. Relative to total assets, debt measured 33.9%, showing how much of the asset base was matched by borrowing. The liabilities-to-assets relationship was 56.2%, placing reported obligations against the full positive asset balance. The cash-to-assets relationship was 3.0%, comparing reported cash and equivalents with the full positive asset balance. Compared with $22.33B in fiscal 2012, the current asset base moved 3.6% and finished higher. Reported equity changed 3.0% from $9.21B in fiscal 2012, placing the current capital base higher year over year.

Cash Flow and Earnings Quality

Cash flow from operations was $2.03B, a reported cash inflow that can be compared directly with net income and capital spending. The operating-cash-flow-to-net-income relationship was 1.83x, comparing cash generated by operations with the bottom-line earnings result. Capital expenditures used $747.94M, identifying the reported investment outflow deducted from operating cash flow in the free-cash-flow calculation. Capital spending absorbed 36.8% of operating cash flow, quantifying the share of cash from operations directed to investment. After capital spending, free cash flow was $1.29B, leaving cash available for debt reduction, shareholder returns, or further investment. Relative to revenue, free cash flow equaled 25.9%, showing how much sales converted into cash after investment. Measured against total assets, free cash flow represented 5.6%, showing the cash productivity of the company’s assets.

Based on the annual report for the fiscal year ending Dec 31, 2013. Analysis generated Sep 24, 2026.